Product Dossier
RIAMET
Product Dossier for RIAMET (artemether, lumefantrine, Novartis Pharmaceuticals). ARTG record, PBS listing, PBAC outcomes — compiled by arcimedes.
- Sponsor: Novartis Pharmaceuticals
- Active ingredient: artemether, lumefantrine
- Therapeutic area: Infectious Disease
- Same area: RETROVIR
- Same area: Savacol Antiseptic Mouth & Throat Rinse
What it is
RIAMET is a combination tablet containing artemether and lumefantrine in a 20 mg/120 mg formulation. The medicine is available as both a standard tablet and a dispersible tablet formulation.
Regulatory history
RIAMET artemether/lumefantrine 20 mg/120 mg tablet was first registered on the ARTG on 24 July 2002. The dispersible tablet formulation was subsequently registered on 9 July 2010.